SOX9 and hepatocellular carcinoma: Moreover, we provide evidence that osteopontin (OPN), another downstream target of the Wnt/beta-catenin pathway32, is regulated by SOX9 and highly expressed in the blood samples from the patients bearing SOX9+ HCC, putting OPN as a surrogate marker of SOX9 in human HCCs.